Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome

FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine for COVID-19

Diagnostic and Interventional Cardiology, 15 Jun 2020

— The U.S. Food and Drug Administration (FDA) today revoked the emergency use authorization (EUA) that allowed use of the drugs…